Glatopa (Glatiramer acetate) for Multiple Sclerosis

Overview
Glatopa is a prescription drug approved by the Food and Drug Administration (FDA) to treat people with relapsing forms of multiple sclerosis. Glatopa is also referred to by its drug name, Glatiramer acetate. Glatopa is a generic version of Copaxone.

Glatopa is an immunomodulator. Glatopa is believed to work by altering the function of the immune system.

How do I take it?
Prescribing information states that Glatopa is taken once daily by subcutaneous injection.

Glatopa comes in prefilled syringes.

Side effects
The FDA-approved label for Glatopa lists common side effects including injection site reactions, rash, chest pain, trouble breathing, and vasodilation (widening of the blood vessels).

Rare but serious side effects listed for Glatopa include lipoatrophy (loss of fat tissue in one area) and skin necrosis (death of skin tissue).

For more details about this treatment, visit:

Glatopa - Sandoz